The Safety and Tolerability of GT0918 in Subjects With mHSPC and mCRPC

Clinical trial NCT03899467 · COMPLETED

Trial details

NCT number: NCT03899467
Sponsor: Suzhou Kintor Pharmaceutical Inc,
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Castrate Resistant Prostate Cancer (mCRPC)Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

Start date: 2019-05-30
Primary completion: 2022-03-31
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.